Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
9
69%
Ph phase_1
1
8%
Ph phase_4
1
8%
Ph phase_3
1
8%
Ph phase_2
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
1(7.7%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
9(69.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
Not yet recruiting2
unknown2
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.7%)
Phase 21 (7.7%)
Phase 31 (7.7%)
Phase 41 (7.7%)
N/A9 (69.2%)

Trials by Status

withdrawn18%
active_not_recruiting18%
completed754%
not_yet_recruiting215%
unknown215%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13